Disabling Utopia to Save It
By s.e. smith,
The Nation
| 07. 14. 2021
Society can benefit from conjuring worlds that model diversity and inclusion.
Imagining better worlds can help us improve our own, but literary and cinematic utopias often exclude those who don’t fit into what are usually racially and culturally homogeneous societies. And whether it’s 1516 or 2016, utopian thinkers are especially prone to leaving out one group whose experiences and insights should enrich our dreams of the future: the disability community.
For centuries, utopias have presented disability as a personal shortcoming to be remedied, not as an identity to be supported and celebrated. A disability in a utopia is socially undesirable—a cause of suffering that does not belong in a place where wholeness of body and spirit is prized. The disability community, however, has a very different view of itself. And understanding what a more inclusive utopia entails shouldn’t just inform attitudes about what constitutes an ideal society; it should shape the way communities approach disability in the real world.
The exclusion of disability from utopias reflects long-standing social attitudes. Throughout much of Western history, disabled people were sequestered, either in institutions or at home. Disability wasn’t a topic of discussion in...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...